Refine by
Eye Pressure Suppliers & Manufacturers
10 companies found
based inVernier-Geneva, SWITZERLAND
Alcon is the global leader in eye care with a heritage of over 75 years. It is the largest eye care device company in the world with businesses in Surgical and Vision Care. Alcon operates in more than 60 countries and serves patients in over 140 ...
Glaucoma is a common eye disease that occurs due to increased pressure in the eye caused by a buildup of excess fluid. The most common form of glaucoma is called primary open-angle glaucoma (POAG), ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential ...
based inWavre, BELGIUM
iSTAR Medical SA, founded in 2011 and headquartered in Wavre, Belgium, is a clinical-stage, medical technology company focused on the development of novel ophthalmic implants for patients with glaucoma. Glaucoma is the second leading cause of adult ...
based inPearl River, NEW YORK (USA)
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a ...
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa ...
based inNorwich, UNITED KINGDOM
Ikarovec was formed as a spin-out from the biotechnology company Quethera, which was acquired by Astellas Pharmaceuticals in 2018. Our technology allows for targeting multiple disease targets and pathways thereby improving efficacy and restoring ...
Ocular hypertension, is defined as having a raised eye pressure greater than 21 mmHg. Ocular hypertension is a proven major risk factor for developing glaucoma and eye drops are recommended to lower ...
based inDepew, NEW YORK (USA)
Reichert Technologies, based in Buffalo, New York, is a global leader in designing, engineering, and manufacturing high-quality diagnostic devices and equipment for ophthalmologists, optometrists, opticians, and retail eye centers. Inventor of ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt ...
based inVantaa, FINLAND
Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection ...
The iCare IC100 and IC200 are quick, reliable, accurate, and easy-to-use tonometers. Elevated eye pressure is the only risk factor of glaucoma that can be affected. Therefore, it is important to ...
based inIrvine, CALIFORNIA (USA)
We create the products and technologies that drive the advancement of aesthetic medicine. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio ...
LATISSE® is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes. ...
based inPhiladelphia, PENNSYLVANIA (USA)
Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients. Glaucoma is the second leading cause of blindness in the world and currently has no cure. To date, Avisi ...
Glaucoma is the second leading cause of blindness in the world and currently has no cure. In glaucoma patients, excess fluid within the eye builds up and puts pressure on the optic nerve. This ...